{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:33Z","timestamp":1786119393536,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1097\/wnf.0b013e3181b52792","type":"journal-article","created":{"date-parts":[[2009,12,2]],"date-time":"2009-12-02T03:16:32Z","timestamp":1259723792000},"page":"326-329","source":"Crossref","is-referenced-by-count":24,"title":["Levodopa-Induced Dyskinesias in Parkinson Disease Are Independent of the Extent of Striatal Dopaminergic Denervation"],"prefix":"10.1097","volume":"32","author":[{"given":"Gurutz","family":"Linazasoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadege","family":"Van Blercom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bergaretxe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki","family":"Fern\u00e1ndez Manchola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Laborda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Angel","family":"Ruiz Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.410390504","article-title":"The response to levodopa in Parkinson's disease: imposing pharmacological law and order.","volume":"39","author":"Nutt","year":"1996","journal-title":"Ann Neurol"},{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/archneur.64.1.141","article-title":"Presynaptic mechanisms of motor complications in Parkinson's disease.","volume":"64","year":"2007","journal-title":"Arch Neurol"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archneur.64.1.137","article-title":"Pathophysiology of motor complications in Parkinson's disease: postsynaptic mechanisms are crucial.","volume":"64","author":"Linazasoro","year":"2007","journal-title":"Arch Neurol"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.","volume":"51","author":"Gibb","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.870070103","article-title":"Core Assessment Program for Intracerebral Transplantation (CAPIT).","volume":"7","author":"Langston","year":"1992","journal-title":"Mov Disord"},{"key":"R7-4-20210203","first-page":"277","article-title":"Modification of dopamine D2 receptor activity by pergolide in Parkinson's disease: an in vivo study by PET.","volume":"22","author":"Linazasoro","year":"1999","journal-title":"Clin Neuropharmacol"},{"key":"R8-4-20210203","first-page":"753","article-title":"One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by 123IFPCIT SPECT.","volume":"40","author":"Booij","year":"1999","journal-title":"J Nucl Med"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","article-title":"Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake.","volume":"154","author":"Benamer","year":"2000","journal-title":"Mov Disord"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.nbd.2005.07.002","article-title":"Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.","volume":"21","author":"Maries","year":"2006","journal-title":"Neurobiol Dis"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/exnr.2002.8055","article-title":"Both short- and long-acting D-1\/D-2 dopamine agonists induce less dyskinesia than L-DOPA in the MPTP-lesioned common marmoset (Callithrix jacchus).","volume":"179","author":"Maratos","year":"2003","journal-title":"Exp Neurol"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/S031716710003849X","article-title":"Risk factors for peak-dose dyskinesia in 100 levodopa-treated parkinsonian patients.","volume":"23","author":"Blanchet","year":"1996","journal-title":"Can J Neurol Sci"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tips.2005.06.007","article-title":"New ideas on the pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: age, genes and neural plasticity.","volume":"26","author":"Linazasoro","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mds.870130605","article-title":"Young-onset Parkinson's disease revisited: clinical features, natural history, and mortality.","volume":"13","author":"Schrag","year":"1998","journal-title":"Mov Disord"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.parkreldis.2006.07.002","article-title":"Cascade of levodopa dose and weight-related dyskinesia in Parkinson's disease (LD-WD-PD cascade).","volume":"12","author":"Sharma","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archneur.62.4.601","article-title":"Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease. An exploratory study.","volume":"62","author":"Zappia","year":"2005","journal-title":"Arch Neurol"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.nbd.2007.02.009","article-title":"Effects of gender on nigral gene expression and Parkinson disease.","volume":"26","author":"Canuti-Castelvetri","year":"2007","journal-title":"Neurobiol Dis"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/wnf.0b013e318050c9f9","article-title":"Hormonal replacement therapy in women with Parkinson's disease and levodopa induced dyskinesias: a cross-over clinical trial.","volume":"30","author":"Nicoletti","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"R19-4-20210203","first-page":"5","article-title":"Plasticity in Parkinson's disease: from compensatory usefulness to negative aberrant behaviours.","volume":"18","author":"Linazasoro","year":"2006","journal-title":"Focus Parkinson Dis"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00002826-200405000-00004","article-title":"Dopamine transporter gene polymorphism, SPECT imaging, and levodopa response in patients with Parkinson disease.","volume":"27","author":"Contin","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"R21-4-20210203","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1212\/WNL.53.7.1425","article-title":"Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD.","volume":"53","author":"Oliveri","year":"1999","journal-title":"Neurology"},{"key":"R22-4-20210203","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000074637","article-title":"Association between catechol-O-methyltransferase gene polymorphisms and wearing-off and dyskinesia in Parkinson's disease.","volume":"48","author":"Watanabe","year":"2003","journal-title":"Neuropsychobiology"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNF.0b013e3181b52792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:07:55Z","timestamp":1786039675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-200911000-00004"}},"subtitle":["A Pharmacological and SPECT Study"],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181b52792","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}